Hyman Charles D Abb Vie Inc. Transaction History

Hyman Charles D

$1.79 Billion
Q2 2024

A detailed history of Hyman Charles D transactions in Abb Vie Inc. stock. As of the latest transaction made, Hyman Charles D holds 29,433 shares of ABBV stock, worth $5.05 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

29,433

Previous 29,585 0.51%

Holding current value

$5.05 Million

Previous $5.39 Million 6.29%

% of portfolio

0.28%

Previous 0.3%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $23,528 - $27,475	-152 Reduced 0.51%	29,433 $5.05 Million
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $122,422 - $139,488	766 Added 2.66%	29,585 $5.39 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $3,440 - $3,874	-25 Reduced 0.09%	28,819 $4.47 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $2 Million - $2.49 Million	-15,116 Reduced 34.39%	28,844 $3.89 Million
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $2.32 Million - $2.68 Million	16,073 Added 57.64%	43,960 $7.01 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $2,684 - $3,078	20 Added 0.07%	27,887 $3.74 Million
Q2 2022 Aug 02, 2022	BUY	$137.62 - $174.96 $14,587 - $18,545	106 Added 0.38%	27,867 $4.27 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $131,980 - $163,750	1,000 Added 3.74%	27,761 $4.5 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $2.6 Million - $3.29 Million	-24,229 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $70,117 - $79,594	-659 Reduced 2.65%	24,229 $2.61 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $130,715 - $176,480	-1,624 Reduced 6.13%	24,888 $2.67 Million
Q3 2020 Oct 26, 2020	SELL	$85.91 - $100.83 $81,614 - $95,788	-950 Reduced 3.46%	26,512 $2.32 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $43,214 - $57,828	589 Added 2.19%	27,462 $2.7 Million
Q1 2020 Apr 30, 2020	SELL	$64.5 - $97.79 $16,125 - $24,447	-250 Reduced 0.92%	26,873 $2.05 Million
Q4 2019 Feb 03, 2020	BUY	$72.13 - $90.25 $22,576 - $28,248	313 Added 1.17%	27,123 $2.4 Million
Q2 2019 Jul 24, 2019	BUY	$65.7 - $83.98 $44,347 - $56,686	675 Added 2.58%	26,810 $1.95 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $385,777 - $454,040	5,001 Added 23.66%	26,135 $2.11 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $105,358 - $117,125	-1,185 Reduced 5.31%	21,134 $2 Million
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $147,774 - $162,046	-1,650 Reduced 6.88%	22,319 $2.16 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $83,820 - $107,064	1,200 Added 5.27%	23,969 $2.13 Million
Q2 2017 Aug 14, 2017	BUY	N/A	22,769	22,769 $1.65 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.

Account